BCB Bancorp Inc (NASDAQ: BCBP) suffers from exceptional negative changes in investment behavior: its longer term price trend turned down, and negative upside/downside volume developed. Recent meaningful negative changes in fundamentals have impacted BCB Bancorp […]
On 2/28/24, vTv Therapeutics Inc (NASDAQ: VTVT) stock enjoyed a major increase of 95.9%, closing at $16.65. Moreover, this advance was accompanied by exceptionally high trading volume at 3499% of normal. The stock has risen […]
Xencor Inc (NASDAQ: XNCR) stock closed at $22.79 on 2/28/24 after a major decline of -14.1%. Moreover, exceptionally high trading volume at 507% of normal accompanied the decline. Relative to the market the stock has […]
Voyager Therapeutics Inc (NASDAQ: VYGR) has reported E.P.S. of $1.28 for its fourth fiscal quarter (ending December 31) versus $-0.61 for the same period a year ago. Relative to the consensus estimate of $-0.16, this […]
The Scripps (E.W.) Co (NASDAQ: SSP) stock closed at $3.97 on 2/28/24 after a major decline of -15.1%. Moreover, trading volume in this decline was exceptionally high at 276% of normal. Relative to the market […]
For its fourth fiscal quarter (ending December 31), The ODP Corporation (NASDAQ: ODP) has reported a -225% decline in E.P.S. from $0.79 a year ago to $-0.99 in the current quarter. Relative to the consensus […]
QuidelOrtho Corporation (NASDAQ: QDEL). Meaningful negative changes in fundamentals have recently occurred: the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased significantly. Significant […]
For its fourth fiscal quarter (ending December 31), Nexstar Media Group Inc. (NASDAQ: NXST) has reported a -38% decline in E.P.S. from $5.42 a year ago to $3.36 in the current quarter. This performance was […]
For its fourth fiscal quarter (ending December 31), Monster Beverage Corp (NASDAQ: MNST) has reported a -40% decline in E.P.S. from $0.58 a year ago to $0.35 in the current quarter. This performance was $-0.04 […]
For its fourth fiscal quarter (ending December 31), Integra LifeSciences Holdings Co (NASDAQ: IART) has reported a -61% decline in E.P.S. from $0.64 a year ago to $0.25 in the current quarter. This result fell […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research